Corcept Therapeutics Inc (NASDAQ:CORT)
| 1.79 Data as of Jun 19 |  -0.04 / -2.19%Today’s Change | 1.27 Today|||52-Week Range 4.55 | +25.17% Year-to-Date |
Latest CORT News | Press Releases
| Assessing Raptor Pharmaceutical's Agreement With HealthCare Royalty Partners Jun 14 / MotleyFool.com |
Today’s Trading
| Previous close | 1.83 |
| Today’s open | 1.81 |
| Day’s range | -- - -- |
| Volume | 92,070 |
| Average volume (3 months) | 125,315 |
| Market cap | $182.7M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -5.13% |
| Earnings growth (this year) | -0.35% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 40.22 |
| Price/Book | 2.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NYMXNymox Pharmaceutical... | +0.02 | +0.37% |
| DRTXDurata Therapeutics ... | -0.10 | -1.41% |
| TGTXTG Therapeutics Inc | +0.02 | +0.28% |
| DVAXDynavax Technologies... | +0.09 | +8.65% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $3.3M |
| Annual profit (last year) | -$38.0M |
| Net profit margin | -1,150.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Joseph K. Belanoff, MD |
President & Secretary Robert L. Roe, MD |
Corporate headquarters Menlo Park, California |
Forecasts
